According to REGENXBIO's latest financial reports the company has โฌ0.23 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $โฌ0.24 B | -11.52% |
2023-12-31 | $โฌ0.28 B | -41.4% |
2022-12-31 | $โฌ0.48 B | -28.69% |
2021-12-31 | $โฌ0.67 B | 119.74% |
2020-12-31 | $โฌ0.30 B | -23.58% |
2019-12-31 | $โฌ0.40 B | -9.65% |
2018-12-31 | $โฌ0.44 B | 191.59% |
2017-12-31 | $โฌ0.15 B | -0.79% |
2016-12-31 | $โฌ0.15 B | -22.45% |
2015-12-31 | $โฌ0.19 B | -4332.35% |
2014-12-31 | $-โฌ4.69 Million | 201.92% |
2013-12-31 | $-โฌ1.56 Million |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | โฌ0.19 B | -19.86% | ๐บ๐ธ USA |